Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Pisa, Italy.
Hum Mutat. 2013 Dec;34(12):1589-96. doi: 10.1002/humu.22430. Epub 2013 Sep 16.
Cornelia de Lange syndrome (CdLS) is a clinically and genetically heterogeneous developmental disorder. Clinical features include growth retardation, intellectual disability, limb defects, typical facial dysmorphism, and other systemic involvement. The increased understanding of the genetic basis of CdLS has led to diagnostic improvement and expansion of the phenotype. Mutations in five genes (NIPBL, SMC1A, SMC3, RAD21, and HDAC8), all regulators or structural components of cohesin, have been identified. Approximately 60% of CdLS cases are due to NIPBL mutations, 5% caused by mutations in SMC1A, RAD21, and HDAC8 and one proband was found to carry a mutation in SMC3. To date, 311 CdLS-causing mutations are known including missense, nonsense, small deletions and insertions, splice site mutations, and genomic rearrangements. Phenotypic variability is seen both intra- and intergenically. This article reviews the spectrum of CdLS mutations with a particular emphasis on their correlation to the clinical phenotype.
康氏综合征(CdLS)是一种临床表现和遗传异质性的发育障碍。临床特征包括生长迟缓、智力障碍、肢体缺陷、典型的面部畸形和其他全身受累。对 CdLS 遗传基础的深入了解导致了诊断的改善和表型的扩展。已经发现了五个基因(NIPBL、SMC1A、SMC3、RAD21 和 HDAC8)的突变,这些基因都是黏合蛋白的调节剂或结构成分。大约 60%的 CdLS 病例是由于 NIPBL 突变引起的,5%是由于 SMC1A、RAD21 和 HDAC8 的突变引起的,一个先证者被发现携带 SMC3 的突变。迄今为止,已经发现了 311 种导致 CdLS 的突变,包括错义、无义、小的缺失和插入、剪接位点突变和基因组重排。在基因内和基因间都存在表型的可变性。本文综述了 CdLS 突变的谱,特别强调了它们与临床表型的相关性。